Position in DXCM
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$16,278,629
+$7,574,989 QoQ
Shares Held
241,702
+74.4% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#164
of 966 holders
Holding Since
Dec 2021
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Tredje AP-fonden holds $165,239,275 across 8 Medical Devices names. DXCM ranks #6 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
467,788 | $42,447,083 | |
| 2 | SYK |
Stryker Corp
|
81,891 | $25,782,562 | |
| 3 | MDT |
Medtronic plc
|
316,249 | $24,740,159 | |
| 4 | EW |
Edwards Lifesciences Corp
|
270,072 | $24,430,713 | |
| 5 | BSX |
Boston Scientific Corp
|
412,667 | $17,612,627 | |
| 6 | DXCM |
Dexcom Inc
This page
|
241,702 | $16,278,629 | |
| 7 | ZBH |
Zimmer Biomet Holdings, Inc.
|
117,984 | $10,157,242 | |
| 8 | STE |
STERIS plc
|
18,000 | $3,790,260 |
All Filings in DXCM
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,278,629 | 241,702 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $8,703,640 | 138,593 | Shares | Sole | 2026-05-12 | |
| 2022-09-30 | $1,119,183 | 13,896 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,035,668 | 13,896 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,777,298 | 3,474 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,865,364 | 3,474 | Shares | Sole | 2022-02-10 | |
| No filing history on record for this holder in this stock. | ||||||